{"title":"跟踪全血细胞计数衍生指数在过渡到心境双相情感障碍:纵向研究。","authors":"Onur Gökçen, Kader Semra Karataş, Merve Akkuş, Feyza Dönmez, Ceyhun Yilmaz, Mete Arslan Konak","doi":"10.1080/17520363.2025.2511469","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>This study aims to investigate changes in the CBC-related inflammatory indices in hospitalized bipolar disorder (BD) patients transitioning from a mood episode to a euthymic state.</p><p><strong>Method: </strong>BD patients hospitalized for mania or depression were assessed during hospitalization and one month post-discharge in euthymia. In both phases, CBC was assessed, along with the administration of YMRS, HDRS-17, and the CGI.</p><p><strong>Results: </strong>Ninety-four patients (58 manic, 36 depressive episodes) met the inclusion criteria at both phases. Significant decreases were observed in WBC (<i>p</i> < 0.001), neutrophils (<i>p</i> = 0.002), platelets (<i>p</i> = 0.038), NLR (neutrophil-to-lymphocyte ratio, <i>p</i> = 0.019), AISI (aggregate index of systemic inflammation, <i>p</i> < 0.001), dNLR (derived neutrophil-to-lymphocyte ratio, <i>p</i> = 0.007), SII (systemic immune inflammation index, <i>p</i> = 0.002), and SIRI (systemic inflammation response index, <i>p</i> = 0.003), while eosinophils (<i>p</i> = 0.003), EMR (eosinophil-to-monocyte ratio, <i>p</i> = 0.002), and ENR (eosinophil-to-neutrophil ratio, <i>p</i> = 0.001) increased. After a Bonferroni correction (<i>p</i> < 0.003125), changes in WBC, neutrophils, AISI, SII, SIRI, EMR, and ENR remained significant. Furthermore, differences were also noted between VPA users and non-users.</p><p><strong>Conclusion: </strong>The study highlights distinctive changes in CBC-related indicators during the transition to euthymia in BD patients. It is the first to investigate specific indices such as AISI, dNLR, EMR, and ENR in BD using a longitudinal design. The findings suggest that CBC-derived inflammation indices are promising tools for monitoring BD clinical progression.</p>","PeriodicalId":9182,"journal":{"name":"Biomarkers in medicine","volume":" ","pages":"425-433"},"PeriodicalIF":1.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140466/pdf/","citationCount":"0","resultStr":"{\"title\":\"Tracking complete blood count-derived indices during transition to euthymia in bipolar disorder: a longitudinal study.\",\"authors\":\"Onur Gökçen, Kader Semra Karataş, Merve Akkuş, Feyza Dönmez, Ceyhun Yilmaz, Mete Arslan Konak\",\"doi\":\"10.1080/17520363.2025.2511469\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>This study aims to investigate changes in the CBC-related inflammatory indices in hospitalized bipolar disorder (BD) patients transitioning from a mood episode to a euthymic state.</p><p><strong>Method: </strong>BD patients hospitalized for mania or depression were assessed during hospitalization and one month post-discharge in euthymia. In both phases, CBC was assessed, along with the administration of YMRS, HDRS-17, and the CGI.</p><p><strong>Results: </strong>Ninety-four patients (58 manic, 36 depressive episodes) met the inclusion criteria at both phases. Significant decreases were observed in WBC (<i>p</i> < 0.001), neutrophils (<i>p</i> = 0.002), platelets (<i>p</i> = 0.038), NLR (neutrophil-to-lymphocyte ratio, <i>p</i> = 0.019), AISI (aggregate index of systemic inflammation, <i>p</i> < 0.001), dNLR (derived neutrophil-to-lymphocyte ratio, <i>p</i> = 0.007), SII (systemic immune inflammation index, <i>p</i> = 0.002), and SIRI (systemic inflammation response index, <i>p</i> = 0.003), while eosinophils (<i>p</i> = 0.003), EMR (eosinophil-to-monocyte ratio, <i>p</i> = 0.002), and ENR (eosinophil-to-neutrophil ratio, <i>p</i> = 0.001) increased. After a Bonferroni correction (<i>p</i> < 0.003125), changes in WBC, neutrophils, AISI, SII, SIRI, EMR, and ENR remained significant. Furthermore, differences were also noted between VPA users and non-users.</p><p><strong>Conclusion: </strong>The study highlights distinctive changes in CBC-related indicators during the transition to euthymia in BD patients. It is the first to investigate specific indices such as AISI, dNLR, EMR, and ENR in BD using a longitudinal design. The findings suggest that CBC-derived inflammation indices are promising tools for monitoring BD clinical progression.</p>\",\"PeriodicalId\":9182,\"journal\":{\"name\":\"Biomarkers in medicine\",\"volume\":\" \",\"pages\":\"425-433\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12140466/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biomarkers in medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17520363.2025.2511469\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/24 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomarkers in medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17520363.2025.2511469","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Tracking complete blood count-derived indices during transition to euthymia in bipolar disorder: a longitudinal study.
Aim: This study aims to investigate changes in the CBC-related inflammatory indices in hospitalized bipolar disorder (BD) patients transitioning from a mood episode to a euthymic state.
Method: BD patients hospitalized for mania or depression were assessed during hospitalization and one month post-discharge in euthymia. In both phases, CBC was assessed, along with the administration of YMRS, HDRS-17, and the CGI.
Results: Ninety-four patients (58 manic, 36 depressive episodes) met the inclusion criteria at both phases. Significant decreases were observed in WBC (p < 0.001), neutrophils (p = 0.002), platelets (p = 0.038), NLR (neutrophil-to-lymphocyte ratio, p = 0.019), AISI (aggregate index of systemic inflammation, p < 0.001), dNLR (derived neutrophil-to-lymphocyte ratio, p = 0.007), SII (systemic immune inflammation index, p = 0.002), and SIRI (systemic inflammation response index, p = 0.003), while eosinophils (p = 0.003), EMR (eosinophil-to-monocyte ratio, p = 0.002), and ENR (eosinophil-to-neutrophil ratio, p = 0.001) increased. After a Bonferroni correction (p < 0.003125), changes in WBC, neutrophils, AISI, SII, SIRI, EMR, and ENR remained significant. Furthermore, differences were also noted between VPA users and non-users.
Conclusion: The study highlights distinctive changes in CBC-related indicators during the transition to euthymia in BD patients. It is the first to investigate specific indices such as AISI, dNLR, EMR, and ENR in BD using a longitudinal design. The findings suggest that CBC-derived inflammation indices are promising tools for monitoring BD clinical progression.
期刊介绍:
Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.
Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.
As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.
Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.
Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.